Over the past three decades, rapid development and application of minimally invasive surgical techniques has fundamentally altered the way urologists care for patients with urologic malignancies. The short-term gains of decreased blood loss, improved convalescence, and improved cosmesis have resulted in the rapid adoption of laparoscopy and robotics, and as a result the vast majority of prostate and kidney surgeries are now performed using the robotic platform in the absence of true long-term outcome improvement or cost benefits.
In this chapter, a series of review articles highlight current controversies surrounding the adoption of minimally invasive surgical techniques for urologic malignancies and summarize the existing literature supporting their use.
Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer
Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
Robotic assisted radical cystectomy versus open radical cystectomy: a review of what we do and don’t know
Contemporary techniques and outcomes of robotic assisted radical cystectomy with intracorporeal urinary diversion
The focused issue “Controversies in Minimally Invasive Urologic Oncology” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Marc C. Smaldone and Jeffrey J. Tomaszewski served as the unpaid Guest Editors for the focused issue.